Search

Your search keyword '"Mescam L"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Mescam L" Remove constraint Author: "Mescam L"
25 results on '"Mescam L"'

Search Results

1. RESISTANCE OF B‐CELL LYMPHOMAS TO CAR‐T CELL THERAPY IS ASSOCIATED WITH HISTOPHENOTYPICAL AND GENOMIC TUMOR CHANGES WHICH CAN INDUCE PROFOUND TRANS‐DIFFERENTIATION

2. JAK-STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI-ALCL PATHOGENESIS?

3. A PHASE II STUDY OF LENALIDOMIDE AND RITUXIMAB (R²) COMBINATION IN PATIENTS WITH HIGH-RISK REFRACTORY/RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA

4. [Non-fatal disseminated mucormycosis in a solid organ transplant]

6. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

7. SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors.

8. A phase II study of lenalidomide and rituximab (R2) combination in patients with high-risk refractory/relapsed diffuse large B-cell lymphoma.

9. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response.

10. Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.

11. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.

12. Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

13. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.

14. EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

15. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

17. [New entities and new tools in hematopathology as proposed by the 2016 WHO classification: Case 2].

18. [New entities and new tools in hematopathology as proposed by the 2016 WHO classification: Case 4].

19. Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour.

20. Common origin of sequential cutaneous CD30+ lymphoproliferations with nodal involvement evidenced by genome-wide clonal evolution.

21. Giant Pedunculated Hepatic Hemangioma: A Case Report and Literature Review.

22. Reversible rituximab-induced rectal Kaposi's sarcoma misdiagnosed as ulcerative colitis in a patient with HIV-negative follicular lymphoma.

23. Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review.

24. [Thyroiditis in an immunocompromised woman].

25. [Non-fatal disseminated mucormycosis in a solid organ transplant].

Catalog

Books, media, physical & digital resources